We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRD
701
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $9.85M | 0.02% |
950,000
| – | – |
|
|
702
CALL
Bank of America
BAC
$436B
| $9.83M | 0.02% |
343,800
-85,000
| -20% | -$2.81M |
|
|
BWC
703
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
| $9.83M | 0.02% |
988,996
-10,624
| -1% | -$105K |
|
704
Alcoa
AA
$11.6B
| $9.81M | 0.02% |
+230,544
| New | +$11.1M |
|
705
Kemper
KMPR
$1.73B
| $9.78M | 0.02% |
178,899
+165,613
| +1,247% | +$9.6M |
|
706
Best Buy
BBY
$18.6B
| $9.77M | 0.02% |
124,771
+99,734
| +398% | +$8.22M |
|
707
Jabil
JBL
$32.6B
| $9.74M | 0.02% |
110,524
-99,932
| -47% | -$8.05M |
|
|
THCP
708
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
| $9.73M | 0.02% |
961,111
| – | – |
|
709
Suncor Energy
SU
$75.6B
| $9.67M | 0.02% |
+311,376
| New | +$10.1M |
|
710
Liberty Energy
LBRT
$2.75B
| $9.61M | 0.02% |
749,856
+537,051
| +252% | +$7.94M |
|
711
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.32B
| $9.6M | 0.02% |
+213,900
| New | +$9.2M |
|
712
Copa Holdings
CPA
$5.65B
| $9.6M | 0.02% |
103,916
-538,293
| -84% | -$48.8M |
|
|
AFTR
713
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
| $9.59M | 0.02% |
937,889
| – | – |
|
714
First Hawaiian
FHB
$3.38B
| $9.56M | 0.02% |
+463,329
| New | +$11.7M |
|
715
CALL
Lockheed Martin
LMT
$134B
| $9.55M | 0.02% |
20,200
-6,100
| -23% | -$2.86M |
|
716
CALL
Pfizer
PFE
$141B
| $9.53M | 0.02% |
233,600
+138,300
| +145% | +$5.97M |
|
717
NCR Voyix
VYX
$1.13B
| $9.5M | 0.02% |
656,377
+255,190
| +64% | +$3.92M |
|
718
CALL
Goldman Sachs
GS
$309B
| $9.45M | 0.02% |
28,900
-21,700
| -43% | -$7.55M |
|
|
XFIN
719
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
| $9.41M | 0.02% |
905,893
-135,591
| -13% | -$1.4M |
|
720
Uranium Energy
UEC
$4.9B
| $9.34M | 0.02% |
3,244,637
+2,606,362
| +408% | +$9.43M |
|
|
OSH
721
DELISTED
Oak Street Health, Inc.
OSH
| $9.34M | 0.02% |
+241,395
| New | +$7.79M |
|
722
GoodRx Holdings
GDRX
$1.03B
| $9.33M | 0.02% |
1,492,983
-1,779,425
| -54% | -$9.92M |
|
723
Transocean
RIG
$5.84B
| $9.32M | 0.02% |
1,465,385
-2,671,828
| -65% | -$17.2M |
|
724
Grupo Aeroportuario del Sureste
ASR
$8.06B
| $9.29M | 0.02% |
30,303
-345
| -1% | -$97.1K |
|
725
Carnival Corporation Ltd
CCL
$37.1B
| $9.29M | 0.02% |
914,918
-6,222,707
| -87% | -$64.5M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.